Search
Foghorn Therapeutics Inc.
FHTXAdd to Watchlist
4.525USD
-0.215-4.54%
Close 07-31 16:00（ET）Quotes delayed by 15 min
265.66MMarket Cap
LossP/E TTM
Foghorn Therapeutics Inc.'s Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Foghorn Therapeutics Inc. is 8.05, ranking 130 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.89, which is -69.32% below the recent high of -1.19 and -52.25% above the recent low of -5.92.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.